Aurora Cannabis (ACB) Receivables (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Receivables data on file, last reported at $31.3 million in Q4 2025.

• Receivables for Q4 2025 came in at $31.3 million, down 6.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $31.3 million (down 6.78% YoY), and the FY2025 annual result was $33.3 million, down 3.22% from the prior year.
• Receivables fell to $31.3 million in Q4 2025 per ACB's latest filing, from $37.2 million in the prior quarter.
• Over five years, Receivables peaked at $669.7 million in Q1 2021 and troughed at $21.8 million in Q2 2024.
• A 5-year average of $64.9 million and a median of $33.1 million in 2022 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2025: Receivables sank 95.52% in 2022, then soared 32.31% in 2025.
• A 5-year view of Receivables shows it stood at $39.6 million in 2021, then declined by 15.89% to $33.3 million in 2022, then dropped by 5.29% to $31.5 million in 2023, then increased by 6.52% to $33.6 million in 2024, then decreased by 6.78% to $31.3 million in 2025.
• Business Quant data shows ACB's Receivables at $31.3 million in Q4 2025, $37.2 million in Q3 2025, and $28.3 million in Q2 2025.